evaluation of cervical status, based on uterine contractility alone and therefore obviating the need for repeated vaginal examination when oral misoprostol is given.
REFERENCES
1.Atterbury JL,Groome LJ,Hoff C,Wheat KA.The diagnosis of premature rupture of the membranes without a sterile speculum examination. Am J Obstet Gynaecol 1998; 178: Abstract No.711, b
2. Sperling LS, Shantz LS, Wahlin A. Management of prelabour rupture of membranes at term.Acta Obstet Gynaecol Scand 1993; 72:627-632
3. Keirse MJ.Prostaglandins in preinduction cervical ripening.A meta-analysis of world wide clinical experience Reprod Med 1993; 38:89-100.
4.Hannah ME, Tan BP.Prostaglandins for prelabour rupture of membrane at or near term.In:Nelson JP,Crowther CA,Hodnet ED,Hofmeyr GJ,editors.Pregnancy and childbirth. Module of The Cochrane Database of Systematic Reviews.Oxford: The Cochrane Collaboration, Update software 1997, c.
5. Windram R, Bennett, K, Mundle W, Young DC.Oral administration of misoprostol for labour induction: a randomized controlled trial.Obstet Gynaecol 1997; 89(3):392-397.
6. Shetty A, Danielian P, Templeton A. Sublingual misoprostol for the induction of labour at term. Am J Obstet Gynaecol 2002; 186:72-76?
Health Vol.9 (1) 2005:7-9
8. www.berkeley.edu/news/media/releases/2006/03/28_misoprostol.
9. Afolabi BB, Oyeneyin OL, Ogedengbe OK.Intravaginal misoprostol versus Foley catheter for cervical ripening and induction of labour.Int J Gynaecol Obstet.2005, 89(3):263-7
10. Okonofua FE, Onwudiegwu U, Odunsi OA.Preterm premature rupture of the membranes in a low socioeconomic population: results of conservative management.Int L Obstet Gynaecol 1990; 34:35.
11. Atterbury JL, Groome LJ, Hoff C, Cruthirds K, Hilton GM, Wheat KA.
The diagnosis of premature rupture of the membranes without a sterile speculum examination. Am J Obstet Gynecol 1998; 178: Abstract #711, b
12. Bank CM, Offermans JP, Gijzen AH, Smits F, van Dieijen-Visser MP, Brombacher PJ.Diamine oxidase activity in amniotic fluid for diagnosis
of ruptured membranes. Eur J Clin Chem Clin Biochem 1991; 29:743- 748.
13. Burchell RC. Premature spontaneous rupture of membranes. Am J Obstet Gynecol 1964; 88:251-255
14. Chua S, Arulkumaran S, Yap C, Selamat N, Ratnam SS. Premature rupture of membranes in nulliparas at term with unfavorable cervices: a Double-blind randomized trial of prostaglandin and placebo. Obstet
15. Duff P, Huff RW, Gibbs RS. Management of premature rupture of membranes and unfavourable cervix in term pregnancy. Obstet Gynecol 1984; 63:697-702.
16. Ekwo EE, Gosselink CA, Woolson R, Moawad A. Risks for
premature rupture of amniotic membranes. Int J Epidemiol 1993; 22:495- 503.
17. Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection.Am J Obstet Gynecol 2000; 164:1317- 1326.
18. Hannah ME, Ohlsson A, Farine D, Hewson SA, Willan AR.Induction of labour compared with expectant management for prelabour rupture of the membranes at term.TERMPROM study group Engl J Med 1996; 334:1005-1010.
19.Shetty A, Stewart K,Stewart G.Active management of term prelabour rupture of membranes with oral misoprostol.Br J Obstet Gynaecol 2002;109:1354-8.
20. Morales WJ, Lazar AJ. Expectant management of rupture of membranes at term. South Med J 2002; 79:955-958.
21. Duff P. Premature rupture of the membranes at term. N Engl J Med 2001;
334:1053-1054.
22. Shalev E, Peleg D, Eliyahu S, et al: Comparison of 12 and 72 hour expectant management of premature rupture of membranes in term pregnancies.Obstet Gynaecol 85:766-768, 1995.
drug warning on misoprostol.ACOG committee opinion no.248.Washington:
American College of Obstetricians and Gynaecologists, 2002.
24. Tang Os, Schweer H, Ho PC.Pharmacokinetics of different routes of administration of misoprostol.Hum Reprod.2002; 17:332-6
25.Danielsson KG,Marisons L,Rodriguez A, Spur BW.Comparison between oral and vaginal administration of misoprostol on uterine contractility.Obstet Gynaecol 1999;93:275-80.
26. Hjertberg R, Hammarstrom M, Moberger B, et al: Premature rupture of the membranes (PROM) at term in nulliparous women with a ripe cervix.Acta Obstet Gynecol Scand 75:48-53, 1996.
27. Natale R, Milne JK, Campbell K, et al: Management of premature rupture of membranes at term: Randomized trial. Am J Obstet Gynecol 171:936-939, 2003.
28. Schuchat A, Whitney C, Zangwill K: Prevention of perinatal group B Streptococcal disease: A public health perspective. MMWR 45(RR-7):1- 24, 1996.
29. Kodkany BS, Telang MA. Premature rupture of membranes: A study of 100 cases. J Obstet Gynaecol Ind 1991; 41:492-6.
Semuzek-Sikora A, Sawulicka-Olesezuk H, Semezuk H.
30. Management of premature rupture of membranes (PROM) at term - own experiences. Ginekol Pol 2001; 72:759-64.
31. Gonen R, Samberg I, Degani S. Intracervical prostaglandin E2 for induction of
Perinatol 1994; 11:436-38.
32. Ben-Haroush A, Yogev Y, Glickman H et al. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labour with vaginal prostaglandin E2. Am J Perinatol 2004; 21:263-68.
33. Hannah ME,Ohlsson A,Farine D.Induction of labour compared with expectant management for prelabour rupture of the membranes at term.N Engl J
med1996; 16:1005-1010.
QUESTIONNAIRE
Age...
Gravida…
Parity…
Gestational Age…
Residence… Rural Urban
Literacy… Illiterate Literate
Socioeconomic status… Lower Middle
Antenatal Care Status… Unbooked Booked
Narcotic… Dosage Time IM/IV Date ---
Type of delivery… SVD? Vacuum? Forceps? LSCS?
Episiotomy…
Side effects… Nausea? Vomiting? Diarrhoea? Other?
ROM (Time)…
Meconium… Yes No
ROM to delivery time. (Mins)…
Induction to delivery (Mins)…
Start of oxytocin to delivery time…
Start of misoprostol to delivery time….
Dose of oxytocin till delivery was achieved…
Stage 3 (Mins)…
Apgar score-1mins.
Apgar score-5mins.
Weight of baby (Kg)...
Admission to Neonatal unit Yes/No
Neonatal complication Yes/No
Maternal death Yes/No
Perinatal death Yes/No
Prostaglandin Dosage Time Date
---
---
---
---
Oxytocin
Time Started--- Bishop Score--- Dose --- Time of Delivery---
POSTPARTUM STUDY SATISFACTION SURVEY PLEASE RATE THE FOLLOWING ON THE BASIS OF STRONGLY AGREE = 5, STRONGLY DISAGREE = 1
1. Where you very satisfied with the care you received during labour/delivery?
2. What did you find most satisfactory about the labour/delivery experience?
3. The most comfortable position was used for the actual delivery?
4. There were too many vaginal examinations?
5. Did you experience any stomach problems during the induction, labour and delivery?
6. Will you have preferred a different means of delivery?
Table 1.baseline characteristics of the women in the Active and Expectant group
Oral misoprostol N=73
Expectant group N=73
Maternal age (yr) (mean + SD)
29.3 + 3.2 28.7 + 3.6
Gestational age(wk) (mean +SD)
38.7 + 1.2 37.5 + 1.2
Parity 0
> 1
42(58%) 31(42%)
44(60%) 29(40%)
Ultrasound to confirm
Gestational age % 90% 92%
Group B on vaginal culture Present
Absent 7%
93%
11%
89%
Table 2. Methods of inducing labour and use of oxytocin during labour in the Active and Conservative groups
Active group n =73 Conservative group n =73
Single dose
Misoprostol only
54 (74%) Nil
Oxytocin only Nil 51(70%)
Repeated misoprostol 19(26%) Nil
Not induced 0 22(30%)
Dose of oxytocin used during labour (% of patients used in)
40 IU (11%) 255 IU (70%)
Table 3.Mode of delivery in Active and Conservative groups
Active group n=42
Conservative group n=44
Z-value P-value
Parity 0 Caesarean section
6(17%) 12(27%) 1.646 0.049
Operative vaginal delivery
2(3%) 6(14%) 2.437 0.007
Spontaneous vaginal delivery
34(80%) 26(59%) 2.962 0.001
TOTAL 42(100%) 44(100%)
Parity > 1 n=31 n=29
Caesarean section
0 0
Operative vaginal delivery
3(10%) 0
Spontaneous vaginal delivery
28(90%) 29(100%) 1.498
TOTAL 31(100%) 29(100%)
Table 4.Postpartum Data Misoprostol
N=73
Expectant group n=73
Relative Risk (RR)
95% CI
Oxytocin use 54 70 0.67 0.38,1.18
Meconium in liquor
21 29 0.78 0.41,1.47
Episiotomy 22 19 1.23 0.62,2.47
Laceration 44 59 0.98 0.56,1.69
Intact Perineum
7 11 1.29 0.72,2.33
Table 5.Labour Interval to Vaginal Birth Oral
misoprostol
Expectant group
P-value
Induction-to delivery interval (Mean+ SD)
816(385) 1032(593) 0.004
Induction to full dilatation (Mean +SD)
763(361) 983(578) .002
1st stage of Labour (Mean +SD)
330(204) 350(223) .48
2nd Stage of Labour (Mean +SD)
73(89) 64(76) .26
3rd Stage of Labour Mean+SD 10(14) 9.9(8.4) .21
Hyperstimulation (No. of subjects)
0 0
Tachysystole (No. of subjects) 7 8 0.7
Nausea /vomiting (No. of subjects)
10 8 0.7
Pyrexia (No. of subjects) 7 8 1.0